Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease vogt-koyanagi-harada disease
Comorbidity C0035305|retinal detachment
Sentences 2
PubMedID- 20689964 Intravitreal bevacizumab injection for persistent serous retinal detachment associated with vogt-koyanagi-harada disease.
PubMedID- 23903795 Conclusion: intravitreal injection of bevacizumab during the corticosteroid therapy may be a treatment option for patients with decreased visual function because of persistent serous retinal detachment associated with vogt-koyanagi-harada syndrome.

Page: 1